Antibiotic origami: selective formation of spirotetronates in abyssomicin biosynthesis
The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs an enzyme-catalysed intramolecular Diels-Alder reac...
Saved in:
Published in | Chemical science (Cambridge) Vol. 15; no. 34; pp. 14009 - 14015 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
12.08.2024
The Royal Society of Chemistry |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs
an enzyme-catalysed intramolecular Diels-Alder reaction, which proceeds
one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts. |
---|---|
AbstractList | The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs
via
an enzyme-catalysed intramolecular Diels–Alder reaction, which proceeds
via
one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts.
The molecular origins of stereoselectivity in enzyme catalysed Diels–Alder reactions in abyssomicin biosynthesis are determined and spirotetronates prepared with the creation of 3 new stereocentres. The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs via an enzyme-catalysed intramolecular Diels–Alder reaction, which proceeds via one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts. The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs via an enzyme-catalysed intramolecular Diels-Alder reaction, which proceeds via one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts.The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs via an enzyme-catalysed intramolecular Diels-Alder reaction, which proceeds via one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts. The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs an enzyme-catalysed intramolecular Diels-Alder reaction, which proceeds one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts. |
Author | Cheung, Kaiman A Back, Catherine R Johns, Samuel T Mulliner, Hannah M Zorn, Katja Mbatha, Sbusisiwe Z van der Kamp, Marc W Devine, Andrew J Stach, James E M Lewin, Harry Willis, Christine L Hayes, Martin A Race, Paul R |
Author_xml | – sequence: 1 givenname: Sbusisiwe Z orcidid: 0000-0002-4097-1034 surname: Mbatha fullname: Mbatha, Sbusisiwe Z email: chris.willis@bristol.ac.uk organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk – sequence: 2 givenname: Catherine R surname: Back fullname: Back, Catherine R organization: School of Biochemistry, University of Bristol Bristol BS8 1TD UK – sequence: 3 givenname: Andrew J orcidid: 0000-0002-4200-5542 surname: Devine fullname: Devine, Andrew J email: chris.willis@bristol.ac.uk organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk – sequence: 4 givenname: Hannah M surname: Mulliner fullname: Mulliner, Hannah M email: chris.willis@bristol.ac.uk organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk – sequence: 5 givenname: Samuel T surname: Johns fullname: Johns, Samuel T organization: School of Biochemistry, University of Bristol Bristol BS8 1TD UK – sequence: 6 givenname: Harry surname: Lewin fullname: Lewin, Harry organization: School of Biochemistry, University of Bristol Bristol BS8 1TD UK – sequence: 7 givenname: Kaiman A orcidid: 0000-0002-2431-3250 surname: Cheung fullname: Cheung, Kaiman A email: chris.willis@bristol.ac.uk organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk – sequence: 8 givenname: Katja surname: Zorn fullname: Zorn, Katja organization: Compound Synthesis and Management, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca Pepparedsleden 1 431 83 Mölndal Sweden – sequence: 9 givenname: James E M surname: Stach fullname: Stach, James E M email: paul.race1@newcastle.ac.uk organization: School of Natural and Environmental Sciences, Newcastle University Newcastle Upon Tyne NE1 7RU UK paul.race1@newcastle.ac.uk – sequence: 10 givenname: Martin A orcidid: 0000-0002-2640-8464 surname: Hayes fullname: Hayes, Martin A organization: Compound Synthesis and Management, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca Pepparedsleden 1 431 83 Mölndal Sweden – sequence: 11 givenname: Marc W orcidid: 0000-0002-8060-3359 surname: van der Kamp fullname: van der Kamp, Marc W organization: School of Biochemistry, University of Bristol Bristol BS8 1TD UK – sequence: 12 givenname: Paul R orcidid: 0000-0003-0184-5630 surname: Race fullname: Race, Paul R email: paul.race1@newcastle.ac.uk organization: School of Natural and Environmental Sciences, Newcastle University Newcastle Upon Tyne NE1 7RU UK paul.race1@newcastle.ac.uk – sequence: 13 givenname: Christine L orcidid: 0000-0002-3919-3642 surname: Willis fullname: Willis, Christine L email: chris.willis@bristol.ac.uk organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39144453$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkd1rFTEQxYNUbK198Q-QBV9EuJpkstmNL6VcWxUKPvjxGrLZSZuym1wzuYX737v98KLOyxyYH4cznOfsIOWEjL0U_J3gYN6PijwH2QI-YUeSK7HSLZiDvZb8kJ0Q3fBlAEQru2fsEIxQSrVwxH6epRqHmGv0TS7xys3xQ0M4oa_xFpuQy-xqzKnJoaFNLLliLTm5itTE1LhhR5Tn6Be9uNAu1WukSC_Y0-AmwpPHfcx-XJx_X39eXX799GV9drny0ui60kq70SCAlp3u-jBIA4PqhUE_cpSh96OUUmndqwADjnxUyvAwBo5CySHAMTt98N1shxlHj6kWN9lNibMrO5tdtP9eUry2V_nWCgGi1y1fHN48OpT8a4tU7RzJ4zS5hHlLFrgB0SnQ_YK-_g-9yduSlv_uqK6XojXdQr19oHzJRAXDPo3g9q4y-1F9W99Xdr7Ar_7Ov0f_FAS_ATYFlMc |
Cites_doi | 10.1039/D4SC02908A 10.1016/j.chembiol.2016.04.002 10.1128/AAC.41.1.1 10.1002/cbic.202300382 10.1021/ol500111n 10.1002/anie.201301680 10.1002/cbic.201100172 10.1038/s41557-022-01104-x 10.1038/nsmb.3326 10.1146/annurev-cellbio-100814-125544 10.1093/emboj/19.6.1176 10.1016/j.bioorg.2014.03.010 10.1101/cshperspect.a018713 10.1021/acsomega.0c02776 10.1021/acs.orglett.8b01997 10.7164/antibiotics.57.271 10.1002/cjoc.202100081 10.1021/acs.orglett.0c01348 10.1002/anie.200502119 10.1039/c39870001625 10.1016/j.chembiol.2016.01.005 10.1002/anie.202213053 10.1039/C6OB02567F 10.1021/jacs.6b00232 10.1016/S0966-842X(97)01033-0 10.1016/j.tcb.2017.01.003 10.1016/j.tibs.2016.07.005 10.1016/j.tet.2017.07.034 |
ContentType | Journal Article |
Copyright | This journal is © The Royal Society of Chemistry. Copyright Royal Society of Chemistry 2024 This journal is © The Royal Society of Chemistry 2024 The Royal Society of Chemistry |
Copyright_xml | – notice: This journal is © The Royal Society of Chemistry. – notice: Copyright Royal Society of Chemistry 2024 – notice: This journal is © The Royal Society of Chemistry 2024 The Royal Society of Chemistry |
DBID | NPM AAYXX CITATION 7SR 8BQ 8FD JG9 7X8 5PM |
DOI | 10.1039/d4sc03253e |
DatabaseName | PubMed CrossRef Engineered Materials Abstracts METADEX Technology Research Database Materials Research Database MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef Materials Research Database Engineered Materials Abstracts Technology Research Database METADEX MEDLINE - Academic |
DatabaseTitleList | Materials Research Database MEDLINE - Academic CrossRef PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 2041-6539 |
EndPage | 14015 |
ExternalDocumentID | 10_1039_D4SC03253E 39144453 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; grantid: EP/S024107/1 – fundername: ; grantid: Unassigned – fundername: ; grantid: BB/L01386X/1; BB/M012107/1; BB/M025624/1; BB/M026280/1; BB/T001968/1 – fundername: ; grantid: EP/L015366/1; EP/L016494/1 |
GroupedDBID | -JG 0-7 0R~ 53G 705 7~J AAEMU AAFWJ AAIWI AAJAE AARTK AAXHV ABEMK ABPDG ABXOH ACGFS ACIWK ADBBV ADMRA AEFDR AENEX AESAV AFLYV AFPKN AGEGJ AGRSR AGSTE AHGCF AKBGW ALMA_UNASSIGNED_HOLDINGS ANUXI AOIJS APEMP AUDPV AZFZN BCNDV BLAPV BSQNT C6K D0L EE0 EF- F5P GROUPED_DOAJ H13 HYE HZ~ H~N NPM O-G O9- OK1 PGMZT R7C R7D RAOCF RCNCU RNS RPM RRC RSCEA RVUXY SKA SKF SKH SKJ SKM SKR SKZ SLC SLF SLH SMJ AAYXX CITATION 7SR 8BQ 8FD JG9 7X8 5PM |
ID | FETCH-LOGICAL-c296t-646ad9e33627678fb293b4819ecd0e2f8cd22246684f3bed0d4490fdf0e142bf3 |
IEDL.DBID | RPM |
ISSN | 2041-6520 |
IngestDate | Tue Sep 17 21:27:38 EDT 2024 Tue Aug 27 04:54:14 EDT 2024 Fri Aug 30 09:40:13 EDT 2024 Wed Sep 04 12:47:06 EDT 2024 Wed Oct 02 05:20:48 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 34 |
Language | English |
License | This journal is © The Royal Society of Chemistry. This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c296t-646ad9e33627678fb293b4819ecd0e2f8cd22246684f3bed0d4490fdf0e142bf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Contributed equally to this work. |
ORCID | 0000-0002-4097-1034 0000-0002-4200-5542 0000-0002-3919-3642 0000-0002-2640-8464 0000-0003-0184-5630 0000-0002-8060-3359 0000-0002-2431-3250 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318650/ |
PMID | 39144453 |
PQID | 3097821597 |
PQPubID | 2047492 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11318650 proquest_miscellaneous_3093174368 proquest_journals_3097821597 crossref_primary_10_1039_D4SC03253E pubmed_primary_39144453 |
PublicationCentury | 2000 |
PublicationDate | 20240812 |
PublicationDateYYYYMMDD | 2024-08-12 |
PublicationDate_xml | – month: 8 year: 2024 text: 20240812 day: 12 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Cambridge |
PublicationTitle | Chemical science (Cambridge) |
PublicationTitleAlternate | Chem Sci |
PublicationYear | 2024 |
Publisher | Royal Society of Chemistry The Royal Society of Chemistry |
Publisher_xml | – name: Royal Society of Chemistry – name: The Royal Society of Chemistry |
References | Moynihan (D4SC03253E/cit1f/1) 2014; 54 Wu (D4SC03253E/cit3a/1) 2014; 16 Byrne (D4SC03253E/cit12/1) 2016; 138 Zapf (D4SC03253E/cit15/1) 2005; 44 Kanchanabanca (D4SC03253E/cit3b/1) 2013; 52 Zamaraev (D4SC03253E/cit1d/1) 2017; 27 Seto (D4SC03253E/cit2b/1) 2014; 6 Davies (D4SC03253E/cit1h/1) 1997; 5 Song (D4SC03253E/cit6a/1) 2017; 73 Drazic (D4SC03253E/cit2a/1) 2016; 1864 Janke (D4SC03253E/cit1b/1) 2015; 31 Gottardi (D4SC03253E/cit7/1) 2011; 12 Zheng (D4SC03253E/cit3c/1) 2016; 15 Hirano (D4SC03253E/cit1a/1) 2016; 23 Kouzarides (D4SC03253E/cit1e/1) 2000; 19 Maschio (D4SC03253E/cit17/1) 2024; 15 Zheng (D4SC03253E/cit11/1) 2016; 23 Wunderlich (D4SC03253E/cit13/1) 2020; 22 Aksnes (D4SC03253E/cit1c/1) 2016; 41 Oikawa (D4SC03253E/cit4/1) 2016; 23 Murray (D4SC03253E/cit1g/1) 1997; 41 Riedlinger (D4SC03253E/cit5/1) 2004; 57 Ding (D4SC03253E/cit6c/1) 2021; 39 Devine (D4SC03253E/cit8/1) 2023; 62 Li (D4SC03253E/cit9/1) 2018; 20 Li (D4SC03253E/cit6b/1) 2020; 5 Wang (D4SC03253E/cit16/1) 2023; 15 Zorn (D4SC03253E/cit10/1) 2023; 24 Griffith (D4SC03253E/cit14/1) 1987; 21 |
References_xml | – volume: 15 start-page: 11572 year: 2024 ident: D4SC03253E/cit17/1 publication-title: Chem. Sci. doi: 10.1039/D4SC02908A contributor: fullname: Maschio – volume: 23 start-page: 429 year: 2016 ident: D4SC03253E/cit4/1 publication-title: Cell Chem. Biol. doi: 10.1016/j.chembiol.2016.04.002 contributor: fullname: Oikawa – volume: 41 start-page: 1 year: 1997 ident: D4SC03253E/cit1g/1 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.41.1.1 contributor: fullname: Murray – volume: 24 start-page: e202300382 year: 2023 ident: D4SC03253E/cit10/1 publication-title: ChemBioChem doi: 10.1002/cbic.202300382 contributor: fullname: Zorn – volume: 16 start-page: 1578 year: 2014 ident: D4SC03253E/cit3a/1 publication-title: Org. Lett. doi: 10.1021/ol500111n contributor: fullname: Wu – volume: 52 start-page: 5785 year: 2013 ident: D4SC03253E/cit3b/1 publication-title: Angew. Chem., Int. Ed. doi: 10.1002/anie.201301680 contributor: fullname: Kanchanabanca – volume: 12 start-page: 1401 year: 2011 ident: D4SC03253E/cit7/1 publication-title: ChemBioChem doi: 10.1002/cbic.201100172 contributor: fullname: Gottardi – volume: 15 start-page: 177 year: 2023 ident: D4SC03253E/cit16/1 publication-title: Nat. Chem. doi: 10.1038/s41557-022-01104-x contributor: fullname: Wang – volume: 23 start-page: 1053 year: 2016 ident: D4SC03253E/cit1a/1 publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/nsmb.3326 contributor: fullname: Hirano – volume: 31 start-page: 473 year: 2015 ident: D4SC03253E/cit1b/1 publication-title: Annu. Rev. Cell Dev. Biol. doi: 10.1146/annurev-cellbio-100814-125544 contributor: fullname: Janke – volume: 19 start-page: 1176 year: 2000 ident: D4SC03253E/cit1e/1 publication-title: EMBO J. doi: 10.1093/emboj/19.6.1176 contributor: fullname: Kouzarides – volume: 54 start-page: 44 year: 2014 ident: D4SC03253E/cit1f/1 publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2014.03.010 contributor: fullname: Moynihan – volume: 1864 start-page: 1372 year: 2016 ident: D4SC03253E/cit2a/1 publication-title: Biochem. Biophys. Acta contributor: fullname: Drazic – volume: 6 start-page: a018713 year: 2014 ident: D4SC03253E/cit2b/1 publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a018713 contributor: fullname: Seto – volume: 5 start-page: 20548 year: 2020 ident: D4SC03253E/cit6b/1 publication-title: ACS Omega doi: 10.1021/acsomega.0c02776 contributor: fullname: Li – volume: 20 start-page: 4854 year: 2018 ident: D4SC03253E/cit9/1 publication-title: Org. Lett. doi: 10.1021/acs.orglett.8b01997 contributor: fullname: Li – volume: 57 start-page: 271 year: 2004 ident: D4SC03253E/cit5/1 publication-title: J. Antibiot. doi: 10.7164/antibiotics.57.271 contributor: fullname: Riedlinger – volume: 39 start-page: 1871 year: 2021 ident: D4SC03253E/cit6c/1 publication-title: Chin. J. Chem. doi: 10.1002/cjoc.202100081 contributor: fullname: Ding – volume: 22 start-page: 4955 year: 2020 ident: D4SC03253E/cit13/1 publication-title: Org. Lett. doi: 10.1021/acs.orglett.0c01348 contributor: fullname: Wunderlich – volume: 44 start-page: 6533 year: 2005 ident: D4SC03253E/cit15/1 publication-title: Angew. Chem., Int. Ed. doi: 10.1002/anie.200502119 contributor: fullname: Zapf – volume: 21 start-page: 1625 year: 1987 ident: D4SC03253E/cit14/1 publication-title: J. Chem. Soc. Chem. Commun. doi: 10.1039/c39870001625 contributor: fullname: Griffith – volume: 23 start-page: 352 year: 2016 ident: D4SC03253E/cit11/1 publication-title: Cell Chem. Biol. doi: 10.1016/j.chembiol.2016.01.005 contributor: fullname: Zheng – volume: 62 start-page: e202213053 year: 2023 ident: D4SC03253E/cit8/1 publication-title: Angew. Chem., Int. Ed. doi: 10.1002/anie.202213053 contributor: fullname: Devine – volume: 15 start-page: 88 year: 2016 ident: D4SC03253E/cit3c/1 publication-title: Org. Biomol. Chem. doi: 10.1039/C6OB02567F contributor: fullname: Zheng – volume: 138 start-page: 6095 year: 2016 ident: D4SC03253E/cit12/1 publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.6b00232 contributor: fullname: Byrne – volume: 5 start-page: 234 year: 1997 ident: D4SC03253E/cit1h/1 publication-title: Trends Microbiol. doi: 10.1016/S0966-842X(97)01033-0 contributor: fullname: Davies – volume: 27 start-page: 311 year: 2017 ident: D4SC03253E/cit1d/1 publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2017.01.003 contributor: fullname: Zamaraev – volume: 41 start-page: 746 year: 2016 ident: D4SC03253E/cit1c/1 publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2016.07.005 contributor: fullname: Aksnes – volume: 73 start-page: 5366 year: 2017 ident: D4SC03253E/cit6a/1 publication-title: Tetrahedron doi: 10.1016/j.tet.2017.07.034 contributor: fullname: Song |
SSID | ssj0000331527 |
Score | 2.4629488 |
Snippet | The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 14009 |
SubjectTerms | Biosynthesis Chemistry Cycloaddition Diels-Alder reactions Dynamic structural analysis Enantiomers Molecular dynamics Natural products Stereoselectivity Substrates |
Title | Antibiotic origami: selective formation of spirotetronates in abyssomicin biosynthesis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39144453 https://www.proquest.com/docview/3097821597/abstract/ https://www.proquest.com/docview/3093174368/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC11318650 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELaAS3up6DtAkVF7Det4HDvuDW1BCImqUkvFLYpfaqSug5rlwL9n7N2s2PbWa8Z5aGbi-cbzIuQTb4y1BmTplJWlqE1X6pRlYcGg_6ydqnOf7euv8vJGXN3WtztETrUwOWnfmv40_l6cxv5Xzq28W9jZlCc2-3Y9ryrURIQWs12yqwCe-Oh5_wVYz2rlTFSlrDmb-pKCnjkxWga8Br9tif6Bl39nST4xOxf75MUaL9Kz1Xe9JDs-viLP5tOYttfk51lMZR8D0mmactUt-s90zNNtcCOjm-JEOgSaourD0qfT7wQxaR9pZx5QQIsUX6f4lPEhIiIc-_ENubk4_zG_LNfDEkrLtVyWUsjOaQ9okBQaoGDQjhuB9t5bxzwPjXU8NY-TjQhgvGNOCM2CC8xXgpsAb8leHKJ_T6gRlWsUOOUqL7T12nDHFF4NzKpgWEE-Toxr71Y9MdocywbdfhHf55m95wU5mnjarv-LsYVUNoIoQ6uCnGzIyLEUpuiiH-7zGkh-kmwK8m4lgs1rQKMDKGooSLMlnM2C1C17m4JKlLtmT0pz8P-3HpLnHDFNOlKu-BHZW_659x8QkyzNcfblj7MiPgJ2AuWZ |
link.rule.ids | 230,315,733,786,790,870,891,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcigXKK8SaMEIrtl1bMeJuVXbVgt0KyRa6C2KHxERbFKR7KH8esbezarbnuCayfuzPd94XgDvWa6N0VzGNjMyFqkuY-WjLAzXaD8rm6WhzvbsTE4vxKfL9HIL5JALE4L2ja5Hza_5qKl_hNjKq7kZD3Fi4y-zSZLgSERqMb4H93HCsuyGlR5WYM5X3VoZFUksU0aHyqRcja3oDOUs5W5TF90hmLfjJG8onpNH8H145WW8yc_Rotcj8-dWNcd__6ZdeLjiouRwKX8MW655AjuToQXcU_h22PiUkhblxHfQKuf1B9KFzjm4SJJ14iNpK-I99m3v_M66p6-kbkiprxH8uffdE7xLd90g2-zq7hlcnByfT6bxqhFDbJiSfSyFLK1yHJVdhsqt0sgRtEAu4YyljlW5scwXppO5qLh2llohFK1sRV0imK74c9hu2sa9AKJFYvOM28wmTijjlGaWZni0oiarNI3g3QBJcbWst1EEPzlXxZH4OgnAHUewP6BVrOZcV3CfkoIMRmURvF2L8Y95F0jZuHYRzuHeBpN5BHtLcNeP4QqNS5HyCPIN2Ncn-ErcmxIEM1TkHsB7-f-XvoGd6fnstDj9ePb5FTxgyJ381nXC9mG7_71wB8h9ev06DPS_NcgG1Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BkYAL70eggBFcs3Fs52Fu1bar8mhVCYoqcYjil4ja9a5I9lB-PeNssuqWW6-x8_zszDee8TcAH1mptFY8j02h81hkqo5lyLLQXKH_LE2R9TrbR8f54an4cpadDVmV7ZBW6bVqJv5iPvHN7z63cjnXyZgnlpwcTdMURyJSi2RpXHIb7uCkZfKKp97_hTkfKrYyKtI4zxgd1Um5TIxoNeUs43bbHv1HMq_nSl4xPrOH8Gt87HXOyflk1amJ_ntN0fFm7_UIHgyclOyt-zyGW9Y_gXvTsRTcU_i558PWkgW2k1BJq543n0jbV9DBnyXZbIAkC0dC5H7R2bDCHmgsaTyp1SUOgnmI4RO8SnvpkXW2TfsMTmcHP6aH8VCQIdZM5l2ci7w20nI0egUaOaeQKyiBnMJqQy1zpTYsCNTlpXBcWUONEJI646hNBVOOP4cdv_D2JRAlUlMW3BQmtUJqKxUztMCjjurCKRrBhxGWarnW3aj6eDmX1b74Pu3BO4hgd0SsGuZeW_GwNQWZjCwieL9pxi8WQiG1t4tV34cHXywvI3ixBnhzGy7RyRQZj6Dcgn7TIShyb7cgoL0y9wjgq5uf-g7unuzPqm-fj7--hvsMKVRYwU7ZLux0f1b2DVKgTr3tx_o_YbEJVQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibiotic+origami%3A+selective+formation+of+spirotetronates+in+abyssomicin+biosynthesis&rft.jtitle=Chemical+science+%28Cambridge%29&rft.au=Mbatha%2C+Sbusisiwe+Z.&rft.au=Back%2C+Catherine+R.&rft.au=Devine%2C+Andrew+J.&rft.au=Mulliner%2C+Hannah+M.&rft.date=2024-08-12&rft.pub=The+Royal+Society+of+Chemistry&rft.issn=2041-6520&rft.eissn=2041-6539&rft_id=info:doi/10.1039%2Fd4sc03253e&rft.externalDBID=PMC11318650 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-6520&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-6520&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-6520&client=summon |